{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:31:02Z","timestamp":1740123062162,"version":"3.37.3"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T00:00:00Z","timestamp":1572652800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T00:00:00Z","timestamp":1572652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s11010-019-03646-0","type":"journal-article","created":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T21:02:41Z","timestamp":1572728561000},"page":"27-38","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["In vitro cellular uptake and neuroprotective efficacy of poly-arginine-18 (R18) and poly-ornithine-18 (O18) peptides: critical role of arginine guanidinium head groups for neuroprotection"],"prefix":"10.1007","volume":"464","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6432-4675","authenticated-orcid":false,"given":"Gabriella","family":"MacDougall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan S.","family":"Anderton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eden","family":"Ouliel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon L.","family":"Redmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neville W.","family":"Knuckey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno P.","family":"Meloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,2]]},"reference":[{"key":"3646_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.pharmthera.2015.06.002","volume":"153","author":"BP Meloni","year":"2015","unstructured":"Meloni BP, Milani D, Edwards AB et al (2015) Neuroprotective peptides fused to arginine-rich cell penetrating peptides: neuroprotective mechanism likely mediated by peptide endocytic properties. Pharmacol Ther 153:36\u201354. https:\/\/doi.org\/10.1016\/j.pharmthera.2015.06.002","journal-title":"Pharmacol Ther"},{"key":"3646_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s12017-017-8441-2","volume":"19","author":"BP Meloni","year":"2017","unstructured":"Meloni BP, Milani D, Cross JL et al (2017) Assessment of the neuroprotective effects of arginine-rich protamine peptides, poly-arginine peptides (R12-Cyclic, R22) and arginine\u2013tryptophan-containing peptides following in vitro excitotoxicity and\/or permanent middle cerebral artery occlusion in rats. NeuroMolecular Med 19:271\u2013285. https:\/\/doi.org\/10.1007\/s12017-017-8441-2","journal-title":"NeuroMolecular Med"},{"key":"3646_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neures.2016.09.002","volume":"114","author":"D Milani","year":"2017","unstructured":"Milani D, Cross JL, Anderton RS et al (2017) Neuroprotective efficacy of poly-arginine R18 and NA-1 (TAT-NR2B9c) peptides following transient middle cerebral artery occlusion in the rat. Neurosci Res 114:9\u201315. https:\/\/doi.org\/10.1016\/j.neures.2016.09.002","journal-title":"Neurosci Res"},{"key":"3646_CR4","first-page":"18","volume":"37","author":"A Edwards","year":"2017","unstructured":"Edwards A, Feindel K, Cross J et al (2017) Neuroprotective efficacy of poly-arginine-18 (R18) peptides using an in vivo model of perinatal hypoxic ischaemic encephalopathy (HIE). J Cereb Blood Flow Metab 37:18\u201319","journal-title":"J Cereb Blood Flow Metab"},{"key":"3646_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s10989-018-09799-8","author":"LS Chiu","year":"2019","unstructured":"Chiu LS, Anderton RS, Cross JL et al (2019) Poly-arginine peptide R18D reduces neuroinflammation and functional deficits following traumatic brain injury in the long-evans rat. Int J Pept Res Ther. https:\/\/doi.org\/10.1007\/s10989-018-09799-8","journal-title":"Int J Pept Res Ther"},{"key":"3646_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1515\/tnsci-2017-0021","volume":"8","author":"LS Chiu","year":"2017","unstructured":"Chiu LS, Anderton RS, Cross JL et al (2017) Assessment of R18, COG1410, and APP96-110 in excitotoxicity and traumatic brain injury. Transl Neurosci 8:147\u2013157. https:\/\/doi.org\/10.1515\/tnsci-2017-0021","journal-title":"Transl Neurosci"},{"key":"3646_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.24315","author":"AB Edwards","year":"2018","unstructured":"Edwards AB, Anderton RS, Knuckey NW, Meloni BP (2018) Assessment of therapeutic window for poly-arginine-18D (R18D) in a P7 rat model of perinatal hypoxic-ischaemic encephalopathy. J Neurosci Res. https:\/\/doi.org\/10.1002\/jnr.24315","journal-title":"J Neurosci Res"},{"key":"3646_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4236\/aad.2018.74011","volume":"7","author":"G Fonar","year":"2018","unstructured":"Fonar G, Polis B, Meirson T et al (2018) Subcutaneous sustained-release of poly-arginine ameliorates cognitive impairment in a transgenic mouse model of Alzheimer\u2019s disease. Adv Alzheimer\u2019s Dis 7:153\u2013182. https:\/\/doi.org\/10.4236\/aad.2018.74011","journal-title":"Adv Alzheimer\u2019s Dis"},{"key":"3646_CR9","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1016\/j.bbamem.2016.07.002","volume":"1858","author":"N Jiang","year":"2016","unstructured":"Jiang N, Frenzel D, Schartmann E et al (2016) Blood-brain barrier penetration of an A\u03b2-targeted, arginine-rich, d-enantiomeric peptide. Biochim Biophys Acta Biomembr 1858:2717\u20132724. https:\/\/doi.org\/10.1016\/j.bbamem.2016.07.002","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"3646_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.vascn.2014.04.001","volume":"70","author":"E Davoli","year":"2014","unstructured":"Davoli E, Sclip A, Cecchi M et al (2014) Determination of tissue levels of a neuroprotectant drug: the cell permeable JNK inhibitor peptide. J Pharmacol Toxicol Methods 70:55\u201361. https:\/\/doi.org\/10.1016\/j.vascn.2014.04.001","journal-title":"J Pharmacol Toxicol Methods"},{"key":"3646_CR11","doi-asserted-by":"publisher","first-page":"11438","DOI":"10.1021\/ja072511s","volume":"129","author":"M Tang","year":"2007","unstructured":"Tang M, Waring AJ, Hong M (2007) Phosphate-mediated arginine insertion into lipid membranes and pore formation by a cationic membrane peptide from solid-state NMR. J Am Chem Soc 129:11438\u201311446. https:\/\/doi.org\/10.1021\/ja072511s","journal-title":"J Am Chem Soc"},{"key":"3646_CR12","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/jcbfm.2015.11","volume":"35","author":"BP Meloni","year":"2015","unstructured":"Meloni BP, Brookes LM, Clark VW et al (2015) Poly-arginine and arginine-rich peptides are neuroprotective in stroke models. J Cereb Blood Flow Metab 35:993\u20131004. https:\/\/doi.org\/10.1038\/jcbfm.2015.11","journal-title":"J Cereb Blood Flow Metab"},{"key":"3646_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10571-013-9999-3","volume":"34","author":"BP Meloni","year":"2014","unstructured":"Meloni BP, Craig AJ, Milech N et al (2014) The neuroprotective efficacy of cell-penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal cultures. Cell Mol Neurobiol 34:173\u2013181. https:\/\/doi.org\/10.1007\/s10571-013-9999-3","journal-title":"Cell Mol Neurobiol"},{"key":"3646_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.nbd.2018.09.010","volume":"121","author":"G MacDougall","year":"2018","unstructured":"MacDougall G, Anderton RS, Mastaglia FL et al (2018) Mitochondria and neuroprotection in stroke: cationic arginine-rich peptides (CARPs) as a novel class of mitochondria-targeted neuroprotective therapeutics. Neurobiol Dis 121:17\u201333. https:\/\/doi.org\/10.1016\/j.nbd.2018.09.010","journal-title":"Neurobiol Dis"},{"key":"3646_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13041-018-0352-0","volume":"11","author":"AB Edwards","year":"2018","unstructured":"Edwards AB, Cross JL, Anderton RS et al (2018) Poly-arginine R18 and R18D (d-enantiomer) peptides reduce infarct volume and improves behavioural outcomes following perinatal hypoxic-ischaemic encephalopathy in the P7 rat. Mol Brain 11:1\u201312. https:\/\/doi.org\/10.1186\/s13041-018-0352-0","journal-title":"Mol Brain"},{"key":"3646_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12868-016-0253-z","volume":"17","author":"D Milani","year":"2016","unstructured":"Milani D, Clark VW, Cross JL et al (2016) Poly-arginine peptides reduce infarct volume in a permanent middle cerebral artery rat stroke model. BMC Neurosci 17:19. https:\/\/doi.org\/10.1186\/s12868-016-0253-z","journal-title":"BMC Neurosci"},{"key":"3646_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.brainresbull.2017.09.012","volume":"135","author":"D Milani","year":"2017","unstructured":"Milani D, Cross JL, Anderton RS et al (2017) Delayed 2-h post-stroke administration of R18 and NA-1 (TAT-NR2B9c) peptides after permanent and\/or transient middle cerebral artery occlusion in the rat. Brain Res Bull 135:62\u201368. https:\/\/doi.org\/10.1016\/j.brainresbull.2017.09.012","journal-title":"Brain Res Bull"},{"key":"3646_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s12031-016-0861-1","volume":"61","author":"G MacDougall","year":"2017","unstructured":"MacDougall G, Anderton RS, Edwards AB et al (2017) The neuroprotective peptide poly-arginine-12 (R12) reduces cell surface levels of NMDA NR2B receptor subunit in cortical neurons; Investigation into the involvement of endocytic mechanisms. J Mol Neurosci 61:235\u2013246. https:\/\/doi.org\/10.1007\/s12031-016-0861-1","journal-title":"J Mol Neurosci"},{"key":"3646_CR19","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1681\/ASN.2010080808","volume":"22","author":"HH Szeto","year":"2011","unstructured":"Szeto HH, Liu S, Soong Y et al (2011) Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury. J Am Soc Nephrol 22:1041\u20131052. https:\/\/doi.org\/10.1681\/ASN.2010080808","journal-title":"J Am Soc Nephrol"},{"key":"3646_CR20","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.bbabio.2015.06.006","volume":"1847","author":"AV Birk","year":"2015","unstructured":"Birk AV, Chao WM, Liu S et al (2015) Disruption of cytochrome c heme coordination is responsible for mitochondrial injury during ischemia. Biochim Biophys Acta 1847:1075\u20131084. https:\/\/doi.org\/10.1016\/j.bbabio.2015.06.006","journal-title":"Biochim Biophys Acta"},{"key":"3646_CR21","doi-asserted-by":"publisher","first-page":"36741","DOI":"10.1074\/jbc.M003848200","volume":"275","author":"A Cameron","year":"2000","unstructured":"Cameron A, Appel J, Houghten RA, Lindberg I (2000) Polyarginines are potent furin inhibitors. J Biol Chem 275:36741\u201336749. https:\/\/doi.org\/10.1074\/jbc.M003848200","journal-title":"J Biol Chem"},{"key":"3646_CR22","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1096\/fj.14-269225","volume":"29","author":"CP Cerrato","year":"2015","unstructured":"Cerrato CP, Pirisinu M, Vlachos EN, Langel \u00dc (2015) Novel cell-penetrating peptide targeting mitochondria. FASEB J 29:4589\u20134599. https:\/\/doi.org\/10.1096\/fj.14-269225","journal-title":"FASEB J"},{"key":"3646_CR23","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nchembio.1393","volume":"9","author":"AL Hilchie","year":"2013","unstructured":"Hilchie AL, Wuerth K, Hancock REW (2013) Immune modulation by multifaceted cationic host defense (antimicrobial) peptides. Nat Chem Biol 9:761\u2013768. https:\/\/doi.org\/10.1038\/nchembio.1393","journal-title":"Nat Chem Biol"},{"key":"3646_CR24","doi-asserted-by":"publisher","DOI":"10.1021\/ja507790z","author":"HD Herce","year":"2014","unstructured":"Herce HD, Garcia AE, Cardoso MC (2014) Fundamental molecular mechanism for the cellular uptake of guanidinium-rich molecules. J Am Chem Soc. https:\/\/doi.org\/10.1021\/ja507790z","journal-title":"J Am Chem Soc"},{"key":"3646_CR25","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1016\/j.bbamem.2012.06.006","volume":"1818","author":"HL \u00c5mand","year":"2012","unstructured":"\u00c5mand HL, Rydberg HA, Fornander LH et al (2012) Cell surface binding and uptake of arginine- and lysine-rich penetratin peptides in absence and presence of proteoglycans. Biochim Biophys Acta Biomembr 1818:2669\u20132678. https:\/\/doi.org\/10.1016\/j.bbamem.2012.06.006","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"3646_CR26","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1021\/bi048046i","volume":"44","author":"E Gon\u00e7alves","year":"2005","unstructured":"Gon\u00e7alves E, Kitas E, Seelig J (2005) Binding of oligoarginine to membrane lipids and heparan sulfate: structural and thermodynamic characterization of a cell-penetrating peptide. Biochemistry 44:2692\u20132702. https:\/\/doi.org\/10.1021\/bi048046i","journal-title":"Biochemistry"},{"key":"3646_CR27","doi-asserted-by":"publisher","first-page":"35109","DOI":"10.1074\/jbc.M301726200","volume":"278","author":"S Console","year":"2003","unstructured":"Console S, Marty C, Garc\u00eda-Echeverr\u00eda C et al (2003) Antennapedia and HIV transactivator of transcription (TAT) \u201cprotein transduction domains\u201d promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J Biol Chem 278:35109\u201335114. https:\/\/doi.org\/10.1074\/jbc.M301726200","journal-title":"J Biol Chem"},{"key":"3646_CR28","doi-asserted-by":"publisher","first-page":"9185","DOI":"10.1021\/bi0346805","volume":"42","author":"A Ziegler","year":"2003","unstructured":"Ziegler A, Li Blatter X, Seelig A, Seelig J (2003) Protein transduction domains of HIV-1 and SIV TAT interact with charged lipid vesicles. Binding mechanism and thermodynamic analysis. Biochemistry 42:9185\u20139190. https:\/\/doi.org\/10.1021\/bi0346805","journal-title":"Biochemistry"},{"key":"3646_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1021\/cr040603j","volume":"105","author":"KA Schug","year":"2005","unstructured":"Schug KA, Lindner W (2005) Noncovalent binding between guanidinium and anionic groups: focus on biological- and synthetic-based arginine\/guanidinium interactions with phosph[on]ate and sulf[on]ate residues. Chem Rev 105:67\u2013114. https:\/\/doi.org\/10.1021\/cr040603j","journal-title":"Chem Rev"},{"key":"3646_CR30","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1021\/acs.bioconjchem.6b00082","volume":"27","author":"Y Kawaguchi","year":"2016","unstructured":"Kawaguchi Y, Takeuchi T, Kuwata K, Chiba J, Hatanaka Y, Nakase I, Futaki S (2016) Syndecan-4 is a receptor for clathrin-mediated endocytosis of arginine-rich cell-penetrating peptides. Bioconjug Chem 27:1119\u20131130. https:\/\/doi.org\/10.1021\/acs.bioconjchem.6b00082","journal-title":"Bioconjug Chem"},{"key":"3646_CR31","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1016\/j.bmcl.2017.10.001","volume":"27","author":"M Bogacheva","year":"2017","unstructured":"Bogacheva M, Egorova A, Slita A et al (2017) Arginine-rich cross-linking peptides with different SV40 nuclear localization signal content as vectors for intranuclear DNA delivery. Bioorg Med Chem Lett 27:4781\u20134785. https:\/\/doi.org\/10.1016\/j.bmcl.2017.10.001","journal-title":"Bioorg Med Chem Lett"},{"key":"3646_CR32","doi-asserted-by":"publisher","first-page":"12625","DOI":"10.1074\/jbc.M311461200","volume":"279","author":"R Fischer","year":"2004","unstructured":"Fischer R, K\u00f6hler K, Fotin-Mleczek M, Brock R (2004) A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides. J Biol Chem 279:12625\u201312635. https:\/\/doi.org\/10.1074\/jbc.M311461200","journal-title":"J Biol Chem"},{"key":"3646_CR33","doi-asserted-by":"publisher","first-page":"6165","DOI":"10.1021\/la040026u","volume":"20","author":"A Pantos","year":"2004","unstructured":"Pantos A, Tsiourvas D, Sideratou Z et al (2004) Interactions of complementary PEGylated liposomes and characterization of the resulting aggregates. Langmuir 20:6165\u20136172. https:\/\/doi.org\/10.1021\/la040026u","journal-title":"Langmuir"},{"key":"3646_CR34","doi-asserted-by":"publisher","first-page":"9506","DOI":"10.1021\/ja0482536","volume":"126","author":"JB Rothbard","year":"2004","unstructured":"Rothbard JB, Jessop TC, Lewis RS et al (2004) Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells. J Am Chem Soc 126:9506\u20139507. https:\/\/doi.org\/10.1021\/ja0482536","journal-title":"J Am Chem Soc"},{"key":"3646_CR35","doi-asserted-by":"publisher","first-page":"16010","DOI":"10.1074\/jbc.272.25.16010","volume":"272","author":"E Viv\u00e8s","year":"1997","unstructured":"Viv\u00e8s E, Brodin P, Lebleu B (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 272:16010\u201316017. https:\/\/doi.org\/10.1074\/jbc.272.25.16010","journal-title":"J Biol Chem"},{"key":"3646_CR36","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1034\/j.1399-3011.2000.00723.x","volume":"56","author":"DJ Mitchell","year":"2000","unstructured":"Mitchell DJ, Steinman L, Kim DT et al (2000) Polyarginine enters cells more efficiently than other polycationic homopolymers. J Pept Res 56:318\u2013325. https:\/\/doi.org\/10.1034\/j.1399-3011.2000.00723.x","journal-title":"J Pept Res"},{"key":"3646_CR37","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1161\/01.str.26.7.1259","volume":"26","author":"JR Brorson","year":"1995","unstructured":"Brorson JR, Marcuccilli CJ, Miller RJ (1995) Delayed antagonism of calpain reduces excitotoxicity in cultured neurons. Stroke 26:1259\u20131266. https:\/\/doi.org\/10.1161\/01.str.26.7.1259","journal-title":"Stroke"},{"key":"3646_CR38","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1111\/j.1471-4159.2005.03122.x","volume":"93","author":"C Volbracht","year":"2005","unstructured":"Volbracht C, Chua BT, Ng CP et al (2005) The critical role of calpain versus caspase activation in excitotoxic injury induced by nitric oxide. J Neurochem 93:1280\u20131292. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03122.x","journal-title":"J Neurochem"},{"key":"3646_CR39","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/sj.bjp.0706279","volume":"145","author":"SW Jones","year":"2005","unstructured":"Jones SW, Christison R, Bundell K et al (2005) Characterisation of cell-penetrating peptide-mediated peptide delivery. Br J Pharmacol 145:1093\u20131102. https:\/\/doi.org\/10.1038\/sj.bjp.0706279","journal-title":"Br J Pharmacol"},{"key":"3646_CR40","doi-asserted-by":"publisher","first-page":"22030","DOI":"10.1074\/jbc.M115.662791","volume":"290","author":"J Marshall","year":"2015","unstructured":"Marshall J, Wong KY, Rupasinghe CN et al (2015) Inhibition of N-Methyl-d-aspartate-induced retinal neuronal death by polyarginine peptides is linked to the attenuation of stress-induced hyperpolarization of the inner mitochondrial membrane potential. J Biol Chem 290:22030\u201322048. https:\/\/doi.org\/10.1074\/jbc.M115.662791","journal-title":"J Biol Chem"},{"key":"3646_CR41","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1021\/mp500203e","volume":"11","author":"D Oh","year":"2014","unstructured":"Oh D, Nasrolahi Shirazi A, Northup K et al (2014) Enhanced cellular uptake of short polyarginine peptides through fatty acylation and cyclization. Mol Pharm 11:2845\u20132854. https:\/\/doi.org\/10.1021\/mp500203e","journal-title":"Mol Pharm"},{"key":"3646_CR42","doi-asserted-by":"publisher","first-page":"16883","DOI":"10.1073\/pnas.1108795108","volume":"108","author":"A Mishra","year":"2011","unstructured":"Mishra A, Lai GH, Schmidt NW et al (2011) Translocation of HIV TAT peptide and analogues induced by multiplexed membrane and cytoskeletal interactions. Proc Natl Acad Sci USA 108:16883\u201316888. https:\/\/doi.org\/10.1073\/pnas.1108795108","journal-title":"Proc Natl Acad Sci USA"},{"key":"3646_CR43","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.4103\/1673-5374.194713","volume":"11","author":"V Li","year":"2016","unstructured":"Li V, Wang YT (2016) Molecular mechanisms of NMDA receptor-mediated excitotoxicity: implications for neuroprotective therapeutics for stroke. Neural Regen Res 11:1752\u20131753. https:\/\/doi.org\/10.4103\/1673-5374.194713","journal-title":"Neural Regen Res"},{"key":"3646_CR44","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1101\/lm.1765710","volume":"26","author":"L Sinai","year":"2010","unstructured":"Sinai L, Duffy S, Roder JC (2010) Src inhibition reduces NR2B surface expression and synaptic plasticity in the amygdala. Learn Mem 26:364\u2013371. https:\/\/doi.org\/10.1101\/lm.1765710","journal-title":"Learn Mem"},{"key":"3646_CR45","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/j.1471-4159.2011.07383.x","volume":"118","author":"DR Cook","year":"2011","unstructured":"Cook DR, Gleichman AJ, Cross SA et al (2011) NMDA receptor modulation by the neuropeptide apelin: implications for excitotoxic injury. J Neurochem 118:1113\u20131123. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07383.x","journal-title":"J Neurochem"},{"key":"3646_CR46","doi-asserted-by":"publisher","first-page":"31375","DOI":"10.1074\/jbc.M109.009951","volume":"284","author":"JM Brittain","year":"2009","unstructured":"Brittain JM, Piekarz AD, Wang Y et al (2009) An atypical role for collapsin response mediator protein 2 (CRMP-2) in neurotransmitter release via interaction with presynaptic voltage-gated calcium channels. J Biol Chem 284:31375\u201331390. https:\/\/doi.org\/10.1074\/jbc.M109.009951","journal-title":"J Biol Chem"},{"key":"3646_CR47","doi-asserted-by":"publisher","first-page":"4351","DOI":"10.1242\/jcs.053280","volume":"122","author":"XX Chi","year":"2009","unstructured":"Chi XX, Schmutzler BS, Brittain JM et al (2009) Regulation of N-type voltage-gated calcium channels (Cav2.2) and transmitter release by collapsin response mediator protein-2 (CRMP-2) in sensory neurons. J Cell Sci 122:4351\u20134362. https:\/\/doi.org\/10.1242\/jcs.053280","journal-title":"J Cell Sci"},{"key":"3646_CR48","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4161\/cib.3.2.10620","volume":"3","author":"Y Wang","year":"2010","unstructured":"Wang Y, Brittain JM, Wilson SM, Khanna R (2010) Emerging roles of collapsin response mediator proteins (CRMPs) as regulators of voltage-gated calcium channels and synaptic transmission. Commun Integr Biol 3:172\u2013175. https:\/\/doi.org\/10.4161\/cib.3.2.10620","journal-title":"Commun Integr Biol"},{"key":"3646_CR49","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1242\/jcs.02460","volume":"118","author":"M Fotin-Mleczek","year":"2005","unstructured":"Fotin-Mleczek M (2005) Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization. J Cell Sci 118:3339\u20133351. https:\/\/doi.org\/10.1242\/jcs.02460","journal-title":"J Cell Sci"},{"key":"3646_CR50","first-page":"746","volume":"24","author":"X-C Weng","year":"2003","unstructured":"Weng X-C, Gai X-D, Zheng J-Q, Li J (2003) Agmatine blocked voltage-gated calcium channel in cultured rat hippocampal neurons. Acta Pharmacol Sin 24:746\u2013750","journal-title":"Acta Pharmacol Sin"},{"key":"3646_CR51","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1161\/01.RES.68.5.1250","volume":"68","author":"E Murphy","year":"1991","unstructured":"Murphy E, Perlman M, London RE, Steenbergen C (1991) Amiloride delays the ischemia-induced rise in cytosolic free calcium. Circ Res 68:1250\u20131258. https:\/\/doi.org\/10.1161\/01.RES.68.5.1250","journal-title":"Circ Res"},{"key":"3646_CR52","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1016\/S0021-9258(19)39660-7","volume":"265","author":"ML Garcia","year":"1990","unstructured":"Garcia ML, King VF, Shevell JL et al (1990) Amiloride analogs inhibit l-type calcium channels and display calcium entry blocker activity. J Biol Chem 265:3763\u20133771","journal-title":"J Biol Chem"},{"key":"3646_CR53","doi-asserted-by":"publisher","first-page":"5631","DOI":"10.1073\/pnas.86.14.5631","volume":"86","author":"JF Keana","year":"1989","unstructured":"Keana JF, McBurney RN, Scherz MW et al (1989) Synthesis and characterization of a series of diarylguanidines that are noncompetitive N-methyl-d-aspartate receptor antagonists with neuroprotective properties. Proc Natl Acad Sci USA 86:5631\u20135635. https:\/\/doi.org\/10.1073\/pnas.86.14.5631","journal-title":"Proc Natl Acad Sci USA"},{"key":"3646_CR54","doi-asserted-by":"publisher","first-page":"9971","DOI":"10.1073\/pnas.1324012111","volume":"11","author":"L Hong","year":"2014","unstructured":"Hong L, Kim IH, Tombola F (2014) Molecular determinants of Hv1 proton channel inhibition by guanidine derivatives. Proc Natl Acad Sci USA 11:9971\u20139976. https:\/\/doi.org\/10.1073\/pnas.1324012111","journal-title":"Proc Natl Acad Sci USA"},{"key":"3646_CR55","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1021\/jm00028a009","volume":"37","author":"NL Reddy","year":"1994","unstructured":"Reddy NL, Hu LY, Cotter RE et al (1994) Synthesis and structure-activity studies of N, N\u2032-Diarylguanidine Derivatives. N-(1-Naphthyl)-N\u2032-(3-ethylphenyl)-N\u2032-methylguanidine: a new, selective noncompetitive NMDA receptor antagonist. J Med Chem 37:260\u2013267. https:\/\/doi.org\/10.1021\/jm00028a009","journal-title":"J Med Chem"},{"key":"3646_CR56","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4068\/cmj.2018.54.1.24","volume":"54","author":"S Jang","year":"2018","unstructured":"Jang S, Park SH (2018) Antidiabetic drug metformin protects neuronal cells against quinolinic acid-induced excitotoxicity by decreasing intracellular calcium. Chonnam Med J 54:24\u201330. https:\/\/doi.org\/10.4068\/cmj.2018.54.1.24","journal-title":"Chonnam Med J"},{"key":"3646_CR57","doi-asserted-by":"publisher","first-page":"E303","DOI":"10.3390\/md15100303","volume":"15","author":"LM Dur\u00e1n-Riveroll","year":"2017","unstructured":"Dur\u00e1n-Riveroll LM, Cembella AD (2017) Guanidinium toxins and their interactions with voltage-gated sodium ion channels. Mar Drugs 15:E303. https:\/\/doi.org\/10.3390\/md15100303","journal-title":"Mar Drugs"},{"key":"3646_CR58","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1124\/mol.111.074989","volume":"80","author":"J Kalia","year":"2011","unstructured":"Kalia J, Swartz KJ (2011) Elucidating the molecular basis of action of a classic drug: guanidine compounds as inhibitors of voltage-gated potassium channels. Mol Pharmacol 80:1085\u20131095. https:\/\/doi.org\/10.1124\/mol.111.074989","journal-title":"Mol Pharmacol"},{"key":"3646_CR59","doi-asserted-by":"publisher","first-page":"18789","DOI":"10.1074\/jbc.TM118.003794","volume":"293","author":"D Bowie","year":"2018","unstructured":"Bowie D (2018) Polyamine-mediated channel block of ionotropic glutamate receptors and its regulation by auxiliary proteins. J Biol Chem 293:18789\u201318802. https:\/\/doi.org\/10.1074\/jbc.TM118.003794","journal-title":"J Biol Chem"},{"key":"3646_CR60","doi-asserted-by":"publisher","first-page":"8175","DOI":"10.1523\/jneurosci.18-20-08175.1998","volume":"18","author":"D Bowie","year":"2018","unstructured":"Bowie D, Lange GD, Mayer ML (2018) Activity-dependent modulation of glutamate receptors by polyamines. J Neurosci 18:8175\u20138185. https:\/\/doi.org\/10.1523\/jneurosci.18-20-08175.1998","journal-title":"J Neurosci"},{"key":"3646_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0898-6568(96)00089-7","volume":"9","author":"K Williams","year":"1997","unstructured":"Williams K (1997) Modulation and block of ion channels: a new biology of polyamines. Cell Signal 9:1\u201313. https:\/\/doi.org\/10.1016\/s0898-6568(96)00089-7","journal-title":"Cell Signal"},{"key":"3646_CR62","doi-asserted-by":"publisher","first-page":"34682","DOI":"10.1074\/jbc.M402999200","volume":"279","author":"K Zhao","year":"2004","unstructured":"Zhao K, Zhao GM, Wu D et al (2004) Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem 279:34682\u201334690. https:\/\/doi.org\/10.1074\/jbc.M402999200","journal-title":"J Biol Chem"},{"key":"3646_CR63","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1006\/bbrc.1995.2756","volume":"217","author":"MP Rigobello","year":"1995","unstructured":"Rigobello MP, Barzon E, Marin O, Bindoli A (1995) Effect of polycation peptides on mitochondrial permeability transition. Biochem Biophys Res Commun 217:144\u2013149. https:\/\/doi.org\/10.1006\/bbrc.1995.2756","journal-title":"Biochem Biophys Res Commun"},{"key":"3646_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/964518","volume":"2015","author":"H Prentice","year":"2015","unstructured":"Prentice H, Modi JP, Wu J-Y (2015) Mechanisms of neuronal protection against excitotoxicity, endoplasmic reticulum stress, and mitochondrial dysfunction in stroke and neurodegenerative diseases. Oxid Med Cell Longev 2015:1\u20137. https:\/\/doi.org\/10.1155\/2015\/964518","journal-title":"Oxid Med Cell Longev"},{"key":"3646_CR65","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1471-2202-7-49","volume":"15","author":"YM Zhang","year":"2006","unstructured":"Zhang YM, Bhavnani BR (2006) Glutamate-induced apoptosis in neuronal cells is mediated via caspase-dependent and independent mechanisms involving calpain and caspase-3 proteases as well as apoptosis inducing factor (AIF) and this process is inhibited by equine estrogens. BMC Neurosci 15:49. https:\/\/doi.org\/10.1186\/1471-2202-7-49","journal-title":"BMC Neurosci"},{"key":"3646_CR66","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1111\/j.1471-4159.2007.04645.x","volume":"102","author":"LA O\u2019Donnell","year":"2007","unstructured":"O\u2019Donnell LA, Agrawal A, Sabnekar P et al (2007) Apelin, an endogenous neuronal peptide, protects hippocampal neurons against excitotoxic injury. J Neurochem 102:1905\u20131917. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04645.x","journal-title":"J Neurochem"},{"key":"3646_CR67","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.neulet.2014.03.037","volume":"568","author":"Y Yang","year":"2014","unstructured":"Yang Y, Zhang X, Cui H et al (2014) Apelin-13 protects the brain against ischemia\/reperfusion injury through activating PI3\u00a0K\/Akt and ERK1\/2 signaling pathways. Neurosci Lett 568:44\u201349. https:\/\/doi.org\/10.1016\/j.neulet.2014.03.037","journal-title":"Neurosci Lett"},{"key":"3646_CR68","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1472-8206.1999.tb00358.x","volume":"13","author":"C Courderot-Masuyer","year":"1999","unstructured":"Courderot-Masuyer C, Dalloz F, Maupoil V, Rochette L (1999) Antioxidant properties of aminoguanidine. Fundam Clin Pharmacol 13:535\u2013540. https:\/\/doi.org\/10.1111\/j.1472-8206.1999.tb00358.x","journal-title":"Fundam Clin Pharmacol"},{"key":"3646_CR69","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.1523\/JNEUROSCI.19-14-05932.1999","volume":"19","author":"JJ Velier","year":"1999","unstructured":"Velier JJ, Ellison JA, Kikly KK et al (1999) Caspase-8 and caspase-3 are expressed by different populations of cortical neurons undergoing delayed cell death after focal stroke in the rat. J Neurosci 19:5932\u20135941","journal-title":"J Neurosci"},{"key":"3646_CR70","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.bbabio.2008.09.006","volume":"1787","author":"L Galluzzi","year":"2009","unstructured":"Galluzzi L, Morselli E, Kepp O, Kroemer G (2009) Targeting post-mitochondrial effectors of apoptosis for neuroprotection. Biochim Biophys Acta Bioenerg 1787:402\u2013413. https:\/\/doi.org\/10.1016\/j.bbabio.2008.09.006","journal-title":"Biochim Biophys Acta Bioenerg"},{"key":"3646_CR71","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.3892\/etm.2019.7423","volume":"17","author":"H Batulu","year":"2019","unstructured":"Batulu H, Du G, Li D et al (2019) Effect of poly-arginine R18 on neurocyte cell growth via autophagy in traumatic brain injury. Exp Ther Med 17:4109\u20134115. https:\/\/doi.org\/10.3892\/etm.2019.7423","journal-title":"Exp Ther Med"},{"key":"3646_CR72","doi-asserted-by":"publisher","first-page":"e0125119","DOI":"10.1371\/journal.pone.0125119","volume":"10","author":"T Chimura","year":"2015","unstructured":"Chimura T, Launey T, Yoshida N (2015) Calpain-mediated degradation of drebrin by excitotoxicity in vitro and in vivo. PLoS ONE 10:e0125119. https:\/\/doi.org\/10.1371\/journal.pone.0125119","journal-title":"PLoS ONE"},{"key":"3646_CR73","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1042\/bj3190683","volume":"1","author":"R Nath","year":"2015","unstructured":"Nath R, Raser KJ, Stafford D et al (2015) Non-erythroid \u03b1-spectrin breakdown by calpain and interleukin 1 \u03b2-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. Biochem J 1:683\u2013690. https:\/\/doi.org\/10.1042\/bj3190683","journal-title":"Biochem J"},{"key":"3646_CR74","doi-asserted-by":"publisher","first-page":"37778","DOI":"10.1074\/jbc.M111.255455","volume":"286","author":"JM Brittain","year":"2011","unstructured":"Brittain JM, Chen L, Wilson SM et al (2011) Neuroprotection against traumatic brain Injury by a peptide derived from the Collapsin Response Mediator Protein 2 (CRMP2). J Biol Chem 286:37778\u201337792. https:\/\/doi.org\/10.1074\/jbc.M111.255455","journal-title":"J Biol Chem"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-019-03646-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-019-03646-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-019-03646-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T21:46:23Z","timestamp":1611697583000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-019-03646-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,2]]},"references-count":74,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["3646"],"URL":"https:\/\/doi.org\/10.1007\/s11010-019-03646-0","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"type":"print","value":"0300-8177"},{"type":"electronic","value":"1573-4919"}],"subject":[],"published":{"date-parts":[[2019,11,2]]},"assertion":[{"value":"28 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"B.P. Meloni and N.W. Knuckey are named inventors of several patent applications (Provisional Patents: 2013904197; 30\/10\/2013 and 2014902319; 17\/6\/2014 and PCT\/AU2014\/050326; 30\/10\/2104) regarding the use of arginine-rich peptides as neuroprotective agents. The other authors declare they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}